Central serotonergic and dopaminergic systems play a critical role in the regulation of normal and abnormal behaviours. Moreover, recent evidence suggests that the dysfunction of dopamine (DA) and serotonin (5-hydroxytriptamine, 5-HT) neurotransmission might underlie the pathophysiology of neuropsychiatric disorders, including depression, schizophrenia, attention deficit hyperactivity disorders, drug abuse, Gilles de la Tourette's syndrome and Parkinson's disease.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/S0079-6123(08)00901-1 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Flavonoids and the gut microbiome: a powerful duo for brain health.
Crit Rev Food Sci Nutr
December 2024
Department of Molecular Biotechnology, Cell Science Research Center, Royan Institute for Biotechnology, ACECR, Isfahan, Iran.
Flavonoids, a class of polyphenolic compounds, are widely distributed in plant-based foods and have been recognized for their potential to promote overall health and well-being. Flavonoids in fruits and vegetables offer various beneficial effects such as anti-aging, anticancer, and anti-inflammatory properties. Flavonoids have been extensively studied for their neuroprotective properties, which are attributed to their ability to cross the blood-brain barrier and interact with neural cells.
View Article and Find Full Text PDFIs There such a Thing as Post-Viral Depression?: Implications for Precision Medicine.
Biomol Ther (Seoul)
November 2024
Department of Psychiatry, Korea University Anam Hospital, Korea University College of Medicine, Seoul 02841, Republic of Korea.
Article Synopsis
- Viral infections, especially after the COVID-19 pandemic, are linked to depressive disorders, with specific viruses like HSV, EBV, CMV, and HIV involved through complex mechanisms.
- These mechanisms include immune system dysregulation, chronic inflammation, and neurotransmitter imbalances that affect brain function and mood.
- The review highlights the importance of developing virus-specific treatments, such as immunomodulatory and antiviral therapies, to better address the unique neurobiological effects of different viruses on depression.
Gray matter volume differences based on sex in first-episode drug-naive patients with major depressive disorder and its molecular analysis.
Neuroreport
December 2024
Department of Psychiatry, the First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan.
This study analyzed whether gray matter volume (GMV) differences exist between the sexes in patients with major depressive disorder (MDD) and explored the relationships between these differences and neurotransmitter systems. This study enrolled 190 first-episode drug-naive patients with MDD and 293 healthy controls. All participants underwent T1-weighted high-resolution MRI.
View Article and Find Full Text PDFMolecular recognition of an odorant by the murine trace amine-associated receptor TAAR7f.
Nat Commun
August 2024
MRC Laboratory of Molecular Biology, Francis Crick Avenue, Cambridge, CB2 0QH, UK.
There are two main families of G protein-coupled receptors that detect odours in humans, the odorant receptors (ORs) and the trace amine-associated receptors (TAARs). Their amino acid sequences are distinct, with the TAARs being most similar to the aminergic receptors such as those activated by adrenaline, serotonin, dopamine and histamine. To elucidate the structural determinants of ligand recognition by TAARs, we have determined the cryo-EM structure of a murine receptor, mTAAR7f, coupled to the heterotrimeric G protein G and bound to the odorant N,N-dimethylcyclohexylamine (DMCHA) to an overall resolution of 2.
View Article and Find Full Text PDFNeuroendocrine mechanisms of mood disorders during menopause transition: A narrative review and future perspectives.
Maturitas
October 2024
Department of Clinical and Experimental Medicine, Division of Gynecology and Obstetrics, University of Pisa, Via Roma 67, 56126 Pisa, PI, Italy. Electronic address:
Article Synopsis
- The menopause transition significantly increases a woman's risk of mood disorders due to fluctuations in estrogen and progesterone levels.
- Low estradiol levels after menopause impact the central nervous system, leading to an imbalance in neurotransmission that can result in symptoms like hot flashes, depression, and anxiety.
- The review highlights the complex neuroendocrine changes occurring during this transition, focusing on the various signaling pathways and neurotransmitters involved in mood alterations.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!